Bellus Health Company
BELLUS Health is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys.
Total Funding:
$44.6M
Technology:
Cancer
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$1M to $10M
Founded Date:
2010
Industry:
PharmTech
Employee Number:
11-50
Acquisitions Number:
2
Funding Status:
IPO
Headquarters:
Canada